Moffitt Cancer Center Launches Immunotherapy Contract Research Organization
October 03, 2019
October 03, 2019
TAMPA, Florida, Oct. 3 -- Moffitt Cancer Center issued the following news release:
Moffitt Cancer Center announced today the launch of a first-of-its-kind contract research organization (CRO) focused on accelerating immunotherapy research. The subsidiary will provide a one-stop-shop for pharmaceutical and biotech companies to accelerate their immuno-oncology and cell therapy research through collaborative clinical trial support and administration.
Immunotherapy is an em . . .
Moffitt Cancer Center announced today the launch of a first-of-its-kind contract research organization (CRO) focused on accelerating immunotherapy research. The subsidiary will provide a one-stop-shop for pharmaceutical and biotech companies to accelerate their immuno-oncology and cell therapy research through collaborative clinical trial support and administration.
Immunotherapy is an em . . .